Given the pivotal role of JMJD3 in the pathogenesis of post-NEC intestinal stenosis, it may work as a promising therapeutic target, thereby offering novel insights for future intervention strategies. The gene discussed is KDM6B; the disease is necrotizing enterocolitis.